James Allison
Internal Medicine · Columbia, SCNPI 1750376521
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.6% of the total across 99 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 25 manufacturers reported payments, led by AstraZeneca at 27.3% of the total. Reporting peaked in 2019 at $1,613 and has fallen 98.4% since, to $26 in 2021.
Across 99 payments — averaging $19.35 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$523
- Novo Nordisk$255
- AbbVie$166
- Boehringer Ingelheim$151
- Amgen$128
- Alkermes, Inc.$125
- plus $567 from 19 others
What the payments were for
- Food & beverage$1,908100%
- Education$70%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 17 | $523 |
| Novo Nordisk | 21 | $255 |
| AbbVie(2 entities) | 6 | $166 |
| Boehringer Ingelheim | 5 | $151 |
| Amgen | 9 | $128 |
| Alkermes, Inc. | 1 | $125 |
| Sanofi-aventis U.S. LLC | 6 | $100 |
| Pfizer | 6 | $82 |
| Lilly USA, LLC | 4 | $48 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 3 | $45 |
| Merck | 3 | $37 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $36 |
| Arbor Pharmaceuticals, Inc. | 2 | $29 |
| Astellas Pharma US Inc | 2 | $28 |
| Radius Health, Inc. | 1 | $25 |
| Daiichi Sankyo Inc. | 1 | $20 |
| Amarin Pharma, Inc. | 1 | $16 |
| Sanofi Pasteur Inc. | 1 | $16 |
| Shire North American Group Inc | 1 | $15 |
| Johnson & Johnson | 1 | $13 |
| Avanir Pharmaceuticals, Inc. | 1 | $13 |
| Novartis | 1 | $13 |
| E.r. Squibb & Sons, L.L.C. | 1 | $11 |
| Hikma Pharmaceuticals USA | 1 | $11 |
| Bardy Diagnostics, Inc. | 1 | $10 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ARISTADA$500
- FARXIGA$245
- ARISTADA INITIO$125
- JARDIANCE$121
How this compares
$1,915 in reported general payments places this provider in the 75th percentile of 1,498 internal medicine providers in South Carolina.
Other internal medicine in Columbia
- Meer FakhryColumbia$22K
- Laura LabooneColumbia$16K
- Charles ButlerColumbia$15K
- Adelero AdebajoColumbia$12K
- Robert CollinsColumbia$11K
- Albert HumphreyColumbia$10K
- Elizabeth LebelColumbia$10K
- Jerry BackNorth Charleston$322K
- Jan BasileCharleston$278K
- Mark PurcellGreenville$165K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.